The transcription factor Elf3, which is one of over 25 Ets family members, is expressed in a wide variety of carcinomas and has been shown to promote the transcription of many genes implicated in cancer. To understand how the Elf3 gene is regulated at the transcriptional level, we probed its 5V-flanking region, and we report here the identification of both proximal and distal regions that regulate murine Elf3 promoter activity. In addition to mapping the transcription start site of the Elf3 gene, the work described in this study identifies four cisregulatory elements in the proximal promoter region of the gene. These include a cis-regulatory element previously designated ESE, a nB site, a POU motif, and a CCAAT box. In addition, we demonstrate that a novel 94 bp region 2 kb upstream of the transcription start site significantly elevates Elf3 promoter activity in F9-differentiated cells, but not in the parental F9 embryonal carcinoma (EC) cells. This region appears to be largely responsible for the increase in Elf3 promoter activity that accompanies the differentiation of embryonal carcinoma cells.
Introduction
Transcription factors belonging to the Ets family play critical roles in normal growth and development, as well as human malignancy (Dittmer and Nordheim, 1998) . Since the discovery of the first Ets family member, over 50 Ets genes have been identified, and at least 25 are expressed in mammals (Laudet et al., 1999) . One Ets family member, Elf3 (also known as ESX, ESE-1, ERT, and JEN), is expressed ubiquitously by epithelial cells (Chang et al., 1997; Oettgen et al., 1997; Tymms et al., 1997) , but it also can be induced in other cell types under pathological conditions (Grall et al., 2003) . The roles of Elf3 have been examined recently in both cell culture and animal models. Inactivation of both alleles of Elf3 by gene targeting leads to fetal lethality (Ng et al., 2002) . Approximately 30% of the null fetuses die around embryonic day 11.5. The 70% that survive to birth exhibit severe alterations in the cellular architecture of the small intestine, including poor villus formation and defective terminal differentiation of the mucus-secreting goblet cells and the absorptive enterocytes. Moreover, enterocytes from Elf3 null animals express significantly reduced levels of type II TGF-h-receptor (ThR-II) at both the RNA and the protein level. Similarly, reduction of Elf3 in a colon cancer cell line by use of an Elf3 antisense retroviral construct also reduced TbR-II expression (Lee et al., 2003) . Other studies have linked Elf3 directly to TbR-II transcription in epithelial cells by its binding to two essential ets-sites in the TbR-II promoter (Choi et al., 1998; Kim et al., 2002; Kopp et al., 2004) . In addition to the TbR-II gene, Elf3 has been implicated in the regulation of multiple genes, including endo A, SPRR2A, SPRRIB, and nitric-oxide synthase (Oettgen et al., 1997; Rudders et al., 2001; Reddy et al., 2003) .
Elf3 also appears to play important roles in cancer, and it is aberrantly expressed in cancers of the lung and breast (Chang et al., 1997) . In the lung, elevated Elf3 expression has been implicated in the expression of the SPRRIB gene, a marker for early metaplastic alterations in bronchial epithelium (Reddy et al., 2003) . In breast cancer, the 1q32 chromosomal region containing Elf3 (Chang et al., 1997) is amplified in 50% of early tumors (Isola et al., 1995) . However, in the case of Hs578t breast cancer cells, Elf3 is expressed at very low levels. Elevating the expression of Elf3 in Hs578t cells dramatically elevates the expression of TbR-II and decreases the tumorigenicity of these cells (Chang et al., 2000) .
Given the important roles of Elf3 in normal cellular physiology and cancer, it is important to determine how transcription of the Elf3 gene is regulated. Sequence analyses of the Elf3 gene have identified several potential transcription factor binding sites in its promoter region, including ets, POU, USF, and nB sites, as well as GC, CCAAT, and TATA boxes (Neve et al., 1998; Oettgen et al., 1999) . Thus far, only the nB site and a novel site, termed an ESE element, in the human ELF3 gene have been shown to be functional (Rudders et al., 2001; Park et al., 2001) . Importantly, other regions of the Elf3 gene have not been examined for their effects on its transcription.
The aim of this study was to identify and characterize cisacting regions of the murine Elf3 gene that control its transcription in early embryonic tumor cells. This work was conducted using murine embryonal carcinoma (EC) cells and their retinoic acid (RA) induced differentiated counterparts, because the steady-state levels of Elf3 mRNA increase at least sixfold when F9 EC cells differentiate (Kim et al., 2002) . Currently, it is unknown whether increases in Elf3 expression influence the differentiation of EC cells, but it is believed to play an important role in the increase in transcription of the TbR-II gene after EC cells differentiate (Kim et al., 2002) .
In this study, we have identified two regions of the Elf3 gene that influence the activity of its promoter. Initially, we mapped the transcription start site of the gene in F9-differentiated cells and tested the function of six potential cis-regulatory elements in the proximal promoter region of the murine Elf3 gene. Importantly, we also demonstrate that differentiation substantially increases the activity of the Elf3 promoter and that this increase in promoter activity is due in large measure to a novel regulatory region located approximately 2 kb upstream of the transcription start site.
Materials and methods
2.1. Cell culture, transfection and luciferase assay F9 EC cells were cultured on gelatinized dishes in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (HyClone, Logan, UT) and antibiotics (Kim et al., 2002; Nowling et al., 2003) . Unless otherwise stated, all chemicals were purchased from Sigma (St. Louis, MO). F9 EC cells were transfected on the day after being seeded at 20,000 cells/well in 24-well plates. For transfection of F9-differentiated cells, F9 EC cells were seeded at 4000 cells/well in 24-well plates and treated with 5 AM RA to induce differentiation. The differentiated cells were transfected 3 days later. Transfections were performed with Lipofectamine and the Plus transfection reagent (Invitrogen) according to the manufacturer's instructions using 400 ng of Elf3 promoter-luciferase plasmids and 200 ng of pRL-TK internal control vector (Promega, Madison, WI). Cells were harvested 24 h after transfection, luciferase activity was measured using a Dualluciferase reporter assay kit (Promega) with a Luminoskan RS plate-reading luminometer (MTX Lab Systems, Vienna, VA), and activities were normalized to the activity of an internal control vector, pRL-TK. Values are presented as the mean F standard error of the mean (S.E.M.) of duplicate or triplicate samples.
Sequencing
The LI-COR and ABI Sequencers at the Genomics Core Research Facility at the University of Nebraska at Lincoln were used along with primer walking to sequence the 5V-flanking region of the mouse Elf3 gene. Both strands were sequenced. The ABI sequencer was also used to verify critical sequences in various plasmids.
Mapping the transcription start site by rapid amplification of cDNA ends (5V-RACE)
The transcription start site of the murine Elf3 gene was determined using 5V-RACE. Two internal primers, 5V-TCTCCCAGAGGTCCAAAGACTAGC-3V (nucleotide position 378 to 401) and 5V-AGCTCCTCCAGCGCA-CAGCTGCAGAGGGTGGCTCC-3V (nucleotide position 340 to 374), were designed based on the Elf3 cDNA sequence (GenBank NM-007921). These two primers were used in conjunction with the RLM 5V-RACE adapter primer (Ambion, Austin, TX) to capture the 5V end of the Elf3 mRNA. The resulting fragments were cloned into the pSP72 vector (Promega). The inserts of 17 recombinant clones were sequenced.
Generation of promoter/reporter gene constructs
The Elf3 promoter region À 338 to + 122 was amplified by PCR from genomic DNA of F9-EC cells. Restriction sites NheI and BglII were incorporated at the ends of the PCR primers to allow insertion into the pGL3-luciferase reporter vector (Promega). PCR primers were designed based on the promoter region sequence from Neve et al. (1998) 5V-GTAGCTAGCGCCAGGCCCCCAGGAAGA-3V (sense) and the cDNA sequence of Tymms et al. (1997) 5V-GTAA-GATCTGGTGTGGCAGGCGGGTGA-3V (antisense). To mutate potential cis-regulatory elements within this sequence, site-directed mutagenesis of the Elf3 promoter Luciferase construct was performed using the ''quick change method'', as described previously (Kim et al., 2002; Nowling et al., 2003) . The following primers were used along with their reverse complements: 5V-CAGATTCTGACAATCATTAAAACTCGAGGCCT-CTGATTTCCAG-3V for ESE mut ; 5V-CAGGAAATCCC-CAGCATCTCGAGAGCCACCAGCTCAGGTTAC-3V for CCAAT m u t ; 5V-AAGTGGCACGGAATATGAATT-TCACCTGGGACAGGGAGCCCAG-3V for POU mut ; and 5V-GGGAGCCCAGTCTGAAGGCCAGTTAATTAA-CAGCATCCAATGAGC-3V for jB mut . The bolded nucleotides are the mutations introduced into the sequence. All promoter sequences were verified by DNA sequencing.
The region of the mouse Elf3 gene from À 2898 to + 703 was inserted into the pGL3-Basic vector between the MluI and HindIII sites to generate the promoter/ reporter construct, mElf3 À 2898/ + 703. Additional promoter/reporter gene constructs lacking portions of this sequence were constructed by digestion with pairs of restriction enzymes, blunting with klenow, and religation. Thus, mElf3 À 2437/ + 703 was generated using MluI and KpnI, mElf3 À 2347/ + 703 using MluI and BglII, mElf3 À 2012/ + 703 using MluI and EcoRI, and mElf3 À 2898/ + 703 D À 2343/ À 2013 using BglII and EcoRI.
To generate mElf3 À 338/ + 703, the promoter region upstream of + 32 was removed from mElf3 À 2898/ + 703 and the fragment À 338/ + 32 was obtained from mElf3 À 338/ + 122 by digestion with KpnI (at an upstream polylinker site) and MscI. The À 338/ + 32 fragment was then inserted into what was left of mElf3 À 2898/ + 703. Additional promoter/reporter constructs were made by inserting various sequences between the KpnI and NheI restriction sites upstream of the promoter in mElf3 À 338/ + 703. Three constructs made in this manner using sequences generated by PCR from mElf3 À 2898/ À 703 were m E l f 3 À 2 3 4 7 / + 7 0 3 D À 2 0 1 2 / À 3 3 9 , m E l f 3 À 2 3 4 7 / + 703 D À 2211/ À 339 , and mElf3 À 2236/ + 703 D À 2142/ À 339 . Another series of constructs made in this manner included various mutations of the Elf3 sequence from À 2236 to À 2143. These mutations were substitutions of 'CCCGGG' in each of 15 positions in the sequence (or 'CGG' in place of the first three bases). In these cases, the sequences to be inserted were obtained by synthesis of smaller overlapping oligonucleotides, which were extended using taq polymerase. All promoter sequences were verified by DNA sequencing.
The promoter/reporter construct, mElf3 À 2347/ + 703 D À 2012/ À 339 , was used in turn to generate two additional constructs. mElf3 À 2347/ + 703 D À 2012/ À 339 was digested with pairs of restriction enzymes, KpnI and EcoRI or EcoRI and NheI, to produce mElf3 À 2093/ + 703 D À 2012/ À 339 and mElf3 À 2347/ + 703 D À 2089/ À 339 , respectively, after blunting with klenow and religation. All promoter sequences were verified by DNA sequencing.
Results

Sequence of the murine Elf3 5V-flanking region
The primary objective of this study was to identify regions of the Elf3 gene required for its transcription. To initiate this study, the murine Elf3 gene from À 2898 to + 703 was sequenced. This sequence has been assigned the GenBank accession number AY456682. To facilitate comparison with previous studies, we have designated the nucleotide positions in this report according to the numerical system of Neve et al. (1998) , who presented an alignment of the human ELF3 and murine Elf3 promoters between À 347 and + 50 of the murine sequence.
Mapping the transcription start site of the murine Elf3 gene
The only published report concerning the transcription start site of the murine Elf3 gene places it 50 bp downstream from a consensus TATA box (Tymms et al., 1997) . However, functional TATA boxes typically direct transcriptional initiation to locations 30 F 2 bp downstream (Bucher, 1990) . Therefore, we mapped the location of the transcription start site of the murine Elf3 gene in F9-differentiated cells. For this purpose, 5V-RACE was used. Seventeen clones were isolated and sequenced, and a dominant transcriptional initiation site (16 out of 17 clones) was identified at nucleotide + 32 (Fig. 1) . This site is 30 bp downstream of the putative TATA box located at + 2. The sequence of the 17th clone in our study corresponds to a start site at nucleotide + 33, and it could have resulted from premature termination during the polymerization step. Thus, it appears that one major start site is employed in F9-differentiated cells. Interestingly, sequence analysis of our 17 clones identified both splice variants of Elf3 mRNA, Elf3a and Elf3b, observed previously in the adult lung of mice (Tymms et al., 1997) . Thus, both Elf3a and Elf3b, which differ by 20 amino acids, may be expressed in F9-differentiated cells.
The proximal promoter region of Elf3 contains at least four cis-regulatory elements
To identify essential cis-regulatory elements in the murine Elf3 gene, we inserted the region between À 338 and + 122 of the Elf3 gene into the promoterless luciferase reporter gene construct, pGL3 Basic, to create mElf3 À 338/ + 122. This construct exhibited 100-fold higher luciferase activity than the parent pGL3 Basic vector (data not shown). Previous analysis of this region (Neve et al., 1998) identified several potential cis-regulatory elements, including a GC box, a USF site, a POU motif, a nB site and a CCAAT box. Of these, only the nB site has been shown to be functional in the human ELF3 gene (Rudders et al., 2001 ). In addition, a novel cisregulatory element referred to as ESE was identified recently in the human ELF3 gene and shown to act as a positive cisregulatory element in a human gastric cancer cell line (Park et al., 2001) . To determine whether any of these potential regulatory sequences are functional in the murine Elf3 gene, each of these sites were disrupted individually in the Elf3 promoter/reporter gene construct mElf3 À 338/ + 122. Disruption of the ESE element and the nB site reduced promoter activity by 48% and 43%, respectively (Fig. 2) . Larger reductions in promoter activity were observed when the POU motif and CCAAT box were mutated, 65% and 71%, respectively. However, disruption of the two GC boxes or the USF site did not reduce Elf3 promoter activity (data not shown). Thus, the proximal promoter region of the Elf3 gene contains at least four cis-regulatory elements that influence its activity, a CCAAT box, a nB site, a POU motif and ESE.
Differentiation of F9 EC cells elevates Elf3 promoter activity
Previous studies demonstrated that differentiation of F9 EC cells leads to significant increases in the steady-state levels of Elf3 mRNA (Kim et al., 2002) . Therefore, we examined whether the activity of the Elf3 promoter increases when EC cells differentiate. Initially, this was examined by transiently transfecting F9 EC cells with mELF3 À 338/ + 122. Five hours after transfecting the cells, the medium was changed and RA was added to one set of F9 EC cells to induce differentiation. In comparison to the untreated F9 EC cells, Elf3 promoter activity increased approximately twofold after a 3-day exposure to RA (Fig.  3A) . This was significantly lower than the sixfold increase in Elf3 mRNA observed previously when F9 EC cells differentiate (Kim et al., 2002) . This raised the possibility that other regions of the Elf3 gene are required for full promoter activity in F9-differentiated cells. To examine this possibility, we generated a murine Elf3 promoter/reporter gene construct that contains a larger region of the Elf3 gene. Fig. 1 . Nucleotide sequence of the region containing the murine Elf3 transcription start site. The transcription start site of murine Elf3 in F9-differentiated cells was determined by 5V -RACE as described in Materials and methods. The major transcription start site is indicated by an arrow. Other sequences of interest are boxed, including potential ESE, POU, and nB elements and CCAAT and TATA boxes. Fig. 2 . Murine Elf3 promoter/reporter activity in F9-differentiated cells. Promoter/reporter constructs with potential cis-regulatory sites mutated (as indicated with an ''X'') were transiently transfected into F9-differentiated cells and assayed for luciferase activity after 48 h as described in Materials and methods. Results were normalized with an internal control and expressed relative to the activity of the unmutated, wild-type, construct mElf3 À 338/ + 122. Values shown are averages F S.E.M. for duplicate samples in a representative experiment. This experiment was performed three times with similar results.
Specifically, we inserted the region À 2898 to + 703 into the promoterless vector pGL3 Basic to generate mElf3 À 2898/ + 703. When this construct was transfected into F9 EC cells, we observed a fivefold increase in promoter activity for F9 cells exposed to RA for 3 days (Fig. 3A) . To confirm and extend these findings, we directly compared the activity of mElf3 À 2898/ + 703 to that of mELF3 À 338/ + 122. There was no significant difference between the activity of the larger and the smaller Elf3 promoter/reporter gene constructs when they were transiently transfected into F9 EC cells (Fig. 3B) . In contrast, when F9 EC cells were transfected after 3 days of RA-induced differentiation, the activity of the larger construct was fivefold higher than the activity of the smaller mElf3 À338/ + 122 construct (Fig. 3B) . Together, these findings argue that at least one region outside the proximal promoter exerts a strong influence on Elf3 promoter activity in F9-differentiated cells.
An upstream regulatory region elevates Elf3 promoter activity
To identify the sequences responsible for elevated promoter activity, we examined the sequences between À 2898 and À 339 and between + 122 and + 703 for their contribution to Elf3 promoter activity. Initially, we created the promoter/reporter gene construct, mElf3 À 338/ + 703 and compared its activity to that of mElf3 À 338/ + 122. In F9-differentiated cells, the activity of mElf3 À 338/ + 703 was only slightly higher (approximately twofold) than that of mElf3 À 338/ + 122 (data not shown). Therefore, we focused our attention on the region between À 2898 and À 339. Additional studies in the future will be needed to identify regulatory sequences located between + 123 and + 703.
To identify sequences upstream of À 338 that influence Elf3 promoter activity, progressively larger amounts of the Elf3 gene between À 2898 and À 2012 were deleted from 5V end of the promoter/reporter gene construct mElf3 À 2898/ + 703. Removal of the region between À 2898 and À 2347 did not reduce Elf3 promoter activity (Fig. 4A) . However, deletion of the region upstream of À 2012 reduced Elf3 promoter activity (Fig. 4A) . This suggested that the region of the Elf3 gene between À 2347 and À 2012 contained one or more cis-regulatory elements that influence its promoter activity in F9-differentiated cells. This possibility was tested by deleting the region À 2343 to À 2013 to generate the construct mElf3 À 2898/+ 703 D À 2343/ À 2013 . When this construct was transfected into F9-differentiated cells, the luciferase activity generated was approximately fourfold lower than that observed with the parent, mElf3 À 2898/ + 703, construct (Fig. 4A) .
The region between À 2347 and À 2012 was examined further using five additional promoter/reporter gene constructs, which incorporated portions of this region inserted into mElf3 À 338/ + 703 upstream of the proximal promoter (Fig. 4B) . Importantly, mElf3 À 2236/ + 703 D À 2142/ À 339 , incorporating the 94 bp sequence from À 2236 to À 2143, exhibited nearly fourfold greater activity than mElf3 À 338/ + 703. To verify the importance of the 94 bp region in the upregulation of the Elf3 promoter when F9 EC cells undergo differentiation, we compared the activity of mElf3 À 2236/ + 703 D À 2142/ À 339 to that of mElf3 À 338/ + 703 in F9 EC cells and F9-differentiated cells. As expected, there was no difference in the activity of these two constructs in F9 EC cells, whereas mElf3 À2236/ + 703 D À 2142/ À 339 exhibited greater than sixfold higher activity in F9-differentiated cells (Fig.  4C) . Hence, we focused the remainder of our efforts in this study on the 94 bp sequence between À 2236 and 2143.
A 36 bp upstream region is required for elevated Elf3 promoter activity
To identify specific DNA sequences within the sequence from À 2236 to À 2143 that are responsible for elevating Elf3 promoter activity, saturation mutagenesis was employed. Specifically, one 3 bp mutant and fifteen 6 bp mutants were generated to sequentially disrupt the entire 94 bp sequence (Fig. 5A) . For this purpose, the wild-type sequence for each of the fifteen 6 bp mutants was replaced with the sequence 5V-CCCGGG-3V. After transient transfection into F9-differentiated cells, the activity of each mutant construct was compared to the activity of mElf3 À 2236/ + 703 D À 2142/ À 339 . This experiment identified a contiguous core of 36 bp (mutants #5 through #10, À 2215 to À 2180) that influenced Elf3 promoter activity (Fig. 5B) . Each of the six mutant constructs, which encompass this 36 bp region, reduced promoter activity. The largest reduction was observed with mutant #9, which eliminated nearly all the activity of the 94 bp sequence.
Thus far, efforts to identify the factors that bind to this 36 bp region have not been successful. Surprisingly, electrophoretic mobility shift assay (EMSA) failed to demonstrate specific binding to this region by any factors in nuclear extracts from F9-differentiated cells (data not shown). In silico analysis identified a region ( À 2216 to À 2211) within the 94 bp sequence that differs by 1 bp from a consensus site for GATA factors (Fig. 5A ). This was of interest, because GATA 4 and GATA 6 expression increases when EC cells undergo differentiation (Morrisey et al., 1996; Murakami et al., 1999) . However, overexpression of neither GATA 4 nor GATA 6 influenced Elf3 promoter activity in F9-differentiated cells (data not shown). Interestingly, this region of the Elf3 gene contains near perfect 7 bp repeats that differ from one another by only 1 bp, and which are separated from each other by 8 bp (Fig. 5A) . However, these sequences do not appear to match the consensus sequence for any known eukaryotic transcription factor.
Discussion
Previous studies have shown that Elf3 mRNA increases at least sixfold after EC cells differentiate (Kim et al., 2002) . However, changes in Elf3 protein levels in this model system have not been determined due to the lack of an antibody that is specific for mouse Elf3. In this study, we examined the DNA regulatory regions that influence the expression of the Elf3 gene. Specifically, we mapped the transcription start site of the murine Elf3 gene in F9-differentiated cells and identified cis-regulatory elements located in the proximal promoter region as well as in a region 2 kb upstream of the transcription start site. The upstream regulatory region is localized to a 36 bp sequence, which appears to play an important role in upregulation of Elf3 when F9 EC cells differentiate.
In this study, 5V-RACE identified a major transcription start site for the murine Elf3 gene in F9-differentiated cells at position + 32, which is 30 bp downstream from the center of a TATA box at + 2. In our study, 16 of the 17 isolated clones identified a start site at position + 32, while the remaining clone corresponded to a start site at + 33. In contrast to our findings, Tymms et al. (1997) used 5V-RACE and mapped the dominant start site in adult murine lung tissue to + 51. In their study, a total of seven clones were sequenced, and four of the seven clones identified a transcription start site at position + 51. The remaining three clones identified start sites at positions + 42, + 44 and + 68, respectively. An analysis of hundreds of genes by Bucher (1990) found the centerto-center spacing between a TATA box and the cap signal to be 30 F 2 bp. It is possible that multiple start sites are used for the Elf3 gene and that different start sites are used in different cell types. However, if functional, the TATA box would direct transcriptional initiation to the site that we identified in F9-differentiated cells rather than to the site found in adult lung. Two studies of the human ELF3 gene have mapped the transcription start site to À 7 in adult liver cells (Oettgen et al., 1999) and À 8 in a gastric cancer cell line (Park et al., 2001) . Oettgen et al. (1999) point out that the difference in start site between the human and murine genes is likely due to the presence of a second TATA box centered at À 39 in the human sequence, which is not present in the murine sequence.
The DNA sequences of the four promoter-proximal cis-regulatory elements (ESE, POU, nB and CCAAT box) shown to be functional in F9-differentiated cells (Fig. 2) are 100% conserved between the mouse and human except for one base pair in the ESE site (Neve et al., 1998) . This is also true for an overlapping CG box and USF site, but disruption of either site on its own or in combination failed to affect Elf3 promoter activity in F9-differentiated cells (data not shown). In contrast to these sites, disruption of the nB site and the ESE site reduced Elf3 promoter activity 43% and 48%, respectively, (Fig.  2) . Earlier studies demonstrated that both sites are functional in the case of the human gene. The nB site was first shown to be functional in the case of the human ELF3 promoter using a mouse monocytic cell line (Rudders et al., 2001 ). This study also reported that the nB site of the human ELF3 gene binds the p50 and p65 subunits of NF-nB in vitro (Rudders et al., 2001) . Moreover, recent evidence argues strongly that p50 and p65 activate the human ELF3 promoter via the nB site in vivo (Grall et al., 2003) . Similar to these findings, we determined that c-Rel and the p50 subunit of NF-nB present in nuclear extracts from F9-differentiated cells can bind to the nB site in vitro (data not shown). The ESE site in the human ELF3 gene was also shown to be functional in an earlier study that used a human gastric tumor cell line (Park et al., 2001) . Interestingly, disruption of the ESE site reduced the activity of the human ELF3 promoter approximately 80% in the gastric tumor cell line. Thus, the overall contribution of the ESE site may differ between the human and the murine gene and/or in different cell types (48% for F9-differentiated cells vs. 80% for gastric tumor cells). Thus far, the nuclear factor shown previously to bind to the ESE site in vitro has not been identified (Park et al., 2001) . Given that the ESE site influences Elf3 promoter activity in at least two cell types, the factor that binds to the ESE site warrants further study. However, it would appear that these studies would be best undertaken using gastric tumor cells.
In this study, we provide the first demonstration that the POU motif and the CCAAT box of this gene influence its promoter activity. Disruption of either site reduced Elf3 promoter activity more than 65% in F9-differentiated cells. In the case of the CCAAT box, we determined by chromatin immunoprecipitation that NF-Y binds to the promoter of the endogenous Elf3 gene in F9-differentiated cells, and we determined that NF-Y mediates the positive effect of the CCAAT box with the use of a dominantnegative mutant of NF-YA (Mantovani et al., 1994 ; data not shown). In other work not described in this report, we determined by electrophoretic mobility shift assay that the transcription factor Oct-1 in nuclear extracts prepared from F9-differentiated cells can bind to the POU motif of the Elf3 gene in vitro. Given the importance of the POU motif, future studies should determine whether Oct-1 binds to the POU motif in F9-differentiated cells and elevates Elf3 promoter activity in vivo.
The work reported in this study argues strongly that an upstream regulatory region plays an important role in elevating Elf3 promoter activity after EC cells undergo differentiation. Earlier studies demonstrated that the steady-state level of Elf3 mRNA increases after EC cells are induced to differentiate, reaching levels approximately sixfold higher after 3 days and eightfold higher after 5 days (Kim et al., 2002) . In the present study, after 3 days of differentiation, the activity of promoter/reporter constructs containing the upstream region is elevated fivefold, while the activity of the proximal promoter appears to increase only twofold (Fig. 3A) . We localized this positive regulatory region to a 94 bp sequence between À 2236 and À 2143 by using a battery of Elf3 promoter/reporter gene constructs containing the proximal promoter and various portions of the 5V-flanking region of the Elf3 gene. In F9-differentiated cells, constructs containing this 94 bp region have four-to sixfold higher activities than constructs without this region. This is in contrast to F9 EC cells, where both sets of constructs have similar activities (Fig. 4C) . Together, our data argue that differentiation of EC cells significantly increases the activity of the Elf3 promoter and that full promoter activity is dependent on a distal regulatory region located 2 kb upstream of the transcription start site of Elf3. Interestingly, this regulatory region functions in a distance-independent manner, given that it functions even when it is placed 2 kb closer to the Elf3 promoter (Fig. 4B) . We also believe that this region is likely to function in an orientation-independent manner, but this was not tested in this study.
Saturation mutagenesis of the 94 bp regulatory region identified a core of 36 bp from À 2215 to À 2180, which is required for full Elf3 promoter activity. The importance of this 36 bp region was demonstrated by six sequential 6 bp mutations, each of which reduced Elf3 promoter activity. Given that the size of this region is far greater than the size of a typical transcription factor binding site (4 -10 bp), and the fact that cis-regulatory elements are often clustered in enhancers, we anticipate that more than one transcription factor binds to this regulatory region. Thus far, we have been unable to identify the factors involved. Efforts to identify proteins that bind to this 36 bp region using electrophoretic mobility shift assay have not been successful.
In conclusion, the work reported in this study establishes that the promoter of the murine Elf3 gene in F9-differentiated cells is controlled by at least four cis-regulatory elements located within 250 bp of the transcription start site. Moreover, we have identified a novel 36 bp regulatory region, which is located 2 kb upstream of the transcription start site. Importantly, this regulatory region exerts a strong influence on the Elf3 promoter activity in F9-differentiated cells and appears to play an important role in the upregulation of Elf3 gene expression after EC cells undergo differentiation. Given that these cells provide an excellent model for mammalian embryogenesis and that differentiation of EC cells strongly suppresses their tumorigenicity (Adamson and Graham, 1980) , it will be of interest to better understand how the Elf3 gene is regulated in this model system. Such an understanding is likely to provide important insights into the regulation of this gene in both normal and diseased tissues.
